Hoda Maarouf, MD
Obstetrics & Gynecology · Oklahoma City, OKNPI 1861694614
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (52.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 43 manufacturers reported payments, led by Intuitive Surgical at 55.7% of the total. Reporting peaked in 2022 at $9,181 and has fallen 89.9% since, to $923 in 2025. Among obstetrics & gynecology clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 368 payments — averaging $39.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$8K
- AbbVie$2K
- Mayne Pharma Commercial LLC$574
- Astellas Pharma US Inc$515
- Bayer$417
- Therapeuticsmd, Inc.$321
- plus $3K from 37 others
What the payments were for
- Travel & lodging$5984%
- Food & beverage$6,35744%
- Education$7,63352%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$7,500
- Da Vinci Surgical System$579
How this compares
$14,588 in reported general payments places this provider in the 95th percentile of 396 obstetrics & gynecology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 38 | $2,985 |
| Ibandronate Sodium | 17 | $780 |
| Levothyroxine Sodium | 25 | $223 |
| Lorazepam | 13 | $67 |
| Zolpidem Tartrate | 20 | $60 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Oklahoma City
- Tori OdanielOklahoma City$917K
- Kathleen MooreOklahoma City$795K
- Beverly VavrickaOklahoma City$22K
- Monica ReidOklahoma City$20K
- Misty WaymanOklahoma City$13K
- Catherine HildebrandOklahoma City$12K
- Catherine GardnerOklahoma City$12K
- Kamal ShanbourOklahoma City$10K
- Darren GoffOklahoma City$10K
- Lisa CheekOklahoma City$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.